商业PRRSV减毒疫苗可能是一种潜在有效的三价活疫苗载体

IF 3.9 3区 生物学 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Yang Li, Yumiao Wang, Xiuxiu Pei, Yongshuai Wu, Shao Chen, Han Weng, Yang Jing, Zhiqian Ma, Zhiwei Li, Zifang Zheng, Yingtong Feng, Lele Xu, Xuyang Guo, Xiao Liu, Jianwu Zhang, Haixue Zheng, Shuqi Xiao
{"title":"商业PRRSV减毒疫苗可能是一种潜在有效的三价活疫苗载体","authors":"Yang Li,&nbsp;Yumiao Wang,&nbsp;Xiuxiu Pei,&nbsp;Yongshuai Wu,&nbsp;Shao Chen,&nbsp;Han Weng,&nbsp;Yang Jing,&nbsp;Zhiqian Ma,&nbsp;Zhiwei Li,&nbsp;Zifang Zheng,&nbsp;Yingtong Feng,&nbsp;Lele Xu,&nbsp;Xuyang Guo,&nbsp;Xiao Liu,&nbsp;Jianwu Zhang,&nbsp;Haixue Zheng,&nbsp;Shuqi Xiao","doi":"10.1007/s00253-025-13502-5","DOIUrl":null,"url":null,"abstract":"<p>PRRSV is an immunosuppressive virus that is prone to secondary infection by other viral and microbial pathogens, exacerbating its harm to pigs. The development of multivalent vaccines that can prevent and control multiple pathogens is of great significance for the pig industry. In order to evaluate the potential of commercial PRRSV vaccines as the viral vectors for the trivalent vaccine, this study first embedded <i>mCherry</i> or <i>EGFP</i> genes for fluorescent proteins into the infectious clone of the HP-PRRSV MLV vaccine strain GD to construct a recombinant strain. Furthermore, we constructed a recombinant PRRSV strain, rPRRSV-mCherry-EGFP, that expresses both EGFP and mCherry proteins simultaneously and evaluated the stability and immunogenicity of the exogenous proteins. The results showed that MARC-145 cells infected with rPRRSV-mCherry-EGFP could simultaneously express both EGFP and mCherry exogenous proteins, and the number of EGFP and mCherry positive cells increased with virus infection, providing more fluorescent tool options for virus visualization and high-throughput screening of anti-PRRSV drugs. More importantly, the recombinant rPRRSV-mCherry-EGFP can be passaged in MARC-145 cells for at least 10 generations. It can induce piglets to produce antibodies against PRRSV, EGFP, and mCherry, indicating that the embedded two exogenous genes can also induce good immune responses. Our research suggests that using the infectious clone of a commercial HP-PRRSV-attenuated vaccine as a vector and embedding immune genes of two other pathogens to construct a recombinant strain may be an effective attempt to achieve cross-protection against three pathogens, providing an important research basis for the design of trivalent vaccines.</p><p>• <i>A recombinant PRRSV that expressed two foreign proteins was constructed.</i></p><p>• <i>The recombinant PRRSV could induce antibodies against PRRSV, EGFP, and mCherry.</i></p><p>• <i>PRRSV MLV strain had the potential to be used as a viral vector for triple vaccines.</i></p>","PeriodicalId":8342,"journal":{"name":"Applied Microbiology and Biotechnology","volume":"109 1","pages":""},"PeriodicalIF":3.9000,"publicationDate":"2025-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00253-025-13502-5.pdf","citationCount":"0","resultStr":"{\"title\":\"The commercial PRRSV attenuated vaccine can be a potentially effective live trivalent vaccine vector\",\"authors\":\"Yang Li,&nbsp;Yumiao Wang,&nbsp;Xiuxiu Pei,&nbsp;Yongshuai Wu,&nbsp;Shao Chen,&nbsp;Han Weng,&nbsp;Yang Jing,&nbsp;Zhiqian Ma,&nbsp;Zhiwei Li,&nbsp;Zifang Zheng,&nbsp;Yingtong Feng,&nbsp;Lele Xu,&nbsp;Xuyang Guo,&nbsp;Xiao Liu,&nbsp;Jianwu Zhang,&nbsp;Haixue Zheng,&nbsp;Shuqi Xiao\",\"doi\":\"10.1007/s00253-025-13502-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>PRRSV is an immunosuppressive virus that is prone to secondary infection by other viral and microbial pathogens, exacerbating its harm to pigs. The development of multivalent vaccines that can prevent and control multiple pathogens is of great significance for the pig industry. In order to evaluate the potential of commercial PRRSV vaccines as the viral vectors for the trivalent vaccine, this study first embedded <i>mCherry</i> or <i>EGFP</i> genes for fluorescent proteins into the infectious clone of the HP-PRRSV MLV vaccine strain GD to construct a recombinant strain. Furthermore, we constructed a recombinant PRRSV strain, rPRRSV-mCherry-EGFP, that expresses both EGFP and mCherry proteins simultaneously and evaluated the stability and immunogenicity of the exogenous proteins. The results showed that MARC-145 cells infected with rPRRSV-mCherry-EGFP could simultaneously express both EGFP and mCherry exogenous proteins, and the number of EGFP and mCherry positive cells increased with virus infection, providing more fluorescent tool options for virus visualization and high-throughput screening of anti-PRRSV drugs. More importantly, the recombinant rPRRSV-mCherry-EGFP can be passaged in MARC-145 cells for at least 10 generations. It can induce piglets to produce antibodies against PRRSV, EGFP, and mCherry, indicating that the embedded two exogenous genes can also induce good immune responses. Our research suggests that using the infectious clone of a commercial HP-PRRSV-attenuated vaccine as a vector and embedding immune genes of two other pathogens to construct a recombinant strain may be an effective attempt to achieve cross-protection against three pathogens, providing an important research basis for the design of trivalent vaccines.</p><p>• <i>A recombinant PRRSV that expressed two foreign proteins was constructed.</i></p><p>• <i>The recombinant PRRSV could induce antibodies against PRRSV, EGFP, and mCherry.</i></p><p>• <i>PRRSV MLV strain had the potential to be used as a viral vector for triple vaccines.</i></p>\",\"PeriodicalId\":8342,\"journal\":{\"name\":\"Applied Microbiology and Biotechnology\",\"volume\":\"109 1\",\"pages\":\"\"},\"PeriodicalIF\":3.9000,\"publicationDate\":\"2025-05-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://link.springer.com/content/pdf/10.1007/s00253-025-13502-5.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Applied Microbiology and Biotechnology\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://link.springer.com/article/10.1007/s00253-025-13502-5\",\"RegionNum\":3,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Applied Microbiology and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://link.springer.com/article/10.1007/s00253-025-13502-5","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

PRRSV是一种免疫抑制病毒,容易被其他病毒和微生物病原体继发感染,加剧了其对猪的危害。研制能够防治多种病原菌的多价疫苗对养猪业具有重要意义。为了评估商业PRRSV疫苗作为三价疫苗载体的潜力,本研究首先将荧光蛋白的mCherry或EGFP基因嵌入HP-PRRSV MLV疫苗株GD的感染性克隆中,构建重组菌株。此外,我们构建了同时表达EGFP和mCherry蛋白的重组PRRSV菌株rPRRSV-mCherry-EGFP,并评估了外源蛋白的稳定性和免疫原性。结果表明,感染rPRRSV-mCherry-EGFP的MARC-145细胞可以同时表达EGFP和mCherry外源蛋白,且EGFP和mCherry阳性细胞数量随病毒感染而增加,为病毒可视化和抗prrsv药物的高通量筛选提供了更多的荧光工具选择。更重要的是,重组rPRRSV-mCherry-EGFP可以在MARC-145细胞中传代至少10代。它能诱导仔猪产生抗PRRSV、EGFP和mCherry的抗体,表明嵌入的两种外源基因也能诱导良好的免疫应答。我们的研究表明,以hp - prrsv减毒疫苗的传染性克隆为载体,嵌入另外两种病原体的免疫基因构建重组菌株,可能是实现对三种病原体交叉保护的有效尝试,为三价疫苗的设计提供重要的研究依据。•构建了表达两种外源蛋白的重组PRRSV。•重组PRRSV可诱导抗PRRSV、EGFP和mCherry的抗体。PRRSV MLV株有可能作为三联疫苗的病毒载体。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The commercial PRRSV attenuated vaccine can be a potentially effective live trivalent vaccine vector

PRRSV is an immunosuppressive virus that is prone to secondary infection by other viral and microbial pathogens, exacerbating its harm to pigs. The development of multivalent vaccines that can prevent and control multiple pathogens is of great significance for the pig industry. In order to evaluate the potential of commercial PRRSV vaccines as the viral vectors for the trivalent vaccine, this study first embedded mCherry or EGFP genes for fluorescent proteins into the infectious clone of the HP-PRRSV MLV vaccine strain GD to construct a recombinant strain. Furthermore, we constructed a recombinant PRRSV strain, rPRRSV-mCherry-EGFP, that expresses both EGFP and mCherry proteins simultaneously and evaluated the stability and immunogenicity of the exogenous proteins. The results showed that MARC-145 cells infected with rPRRSV-mCherry-EGFP could simultaneously express both EGFP and mCherry exogenous proteins, and the number of EGFP and mCherry positive cells increased with virus infection, providing more fluorescent tool options for virus visualization and high-throughput screening of anti-PRRSV drugs. More importantly, the recombinant rPRRSV-mCherry-EGFP can be passaged in MARC-145 cells for at least 10 generations. It can induce piglets to produce antibodies against PRRSV, EGFP, and mCherry, indicating that the embedded two exogenous genes can also induce good immune responses. Our research suggests that using the infectious clone of a commercial HP-PRRSV-attenuated vaccine as a vector and embedding immune genes of two other pathogens to construct a recombinant strain may be an effective attempt to achieve cross-protection against three pathogens, providing an important research basis for the design of trivalent vaccines.

A recombinant PRRSV that expressed two foreign proteins was constructed.

The recombinant PRRSV could induce antibodies against PRRSV, EGFP, and mCherry.

PRRSV MLV strain had the potential to be used as a viral vector for triple vaccines.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Applied Microbiology and Biotechnology
Applied Microbiology and Biotechnology 工程技术-生物工程与应用微生物
CiteScore
10.00
自引率
4.00%
发文量
535
审稿时长
2 months
期刊介绍: Applied Microbiology and Biotechnology focusses on prokaryotic or eukaryotic cells, relevant enzymes and proteins; applied genetics and molecular biotechnology; genomics and proteomics; applied microbial and cell physiology; environmental biotechnology; process and products and more. The journal welcomes full-length papers and mini-reviews of new and emerging products, processes and technologies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信